Key result
Intensively lowered LDL-C was associated with a lower incidence of deferred lesion failure compared to LDL-C ≥/dL.
Why the study?
Lowering LDL-C reduces cardiovascular events, but its benefit on deferred lesion prognosis after FFR-based revascularization deferral has not been well evaluated.
Does achieving LDL-C <70 mg/dL reduce deferred lesion failure in patients with stable coronary artery disease and FFR-deferred lesions?
Observational (n=192)
No
Does achieving LDL-C <70 mg/dL reduce deferred lesion failure in patients with stable coronary artery disease and FFR-deferred lesions?
Achieving an LDL-C <70 mg/dL is associated with a significantly lower rate of deferred lesion failure in patients with stable CAD and FFR-deferred lesions.
Answers are grounded in this paper and cite their sources.
May support LDL-C <70 target in FFR-deferred lesions; leaves open causal benefit pending RCTs.
OBJECTIVES: The aim of this study was to investigate the impact of intensively lowered low-density lipoprotein cholesterol (LDL-C) level on the deferred lesion prognosis after revascularization deferral based on fractional flow reserve (FFR). BACKGROUND: Lowering LDL-C is associated with lower cardiovascular event rate, but its benefit on the deferred lesion prognosis has not been well evaluated. METHODS: This retrospective, single-center, observational study analyzed 192 deferred lesions with FFR value >0.80 in 192 patients with stable coronary artery disease. According to the first follow-up LDL-C level, they were assigned to the LOW group (<70 mg/dL) or the HIGH group (≥70 mg/dL). Deferred lesion failure (DLF) was defined as the composite of deferred lesion revascularization and deferred vessel myocardial infarction. RESULTS: Of all participants, 61 and 131 patients were assigned to the LOW and the HIGH group, respectively. During the median follow-up of 2.8 years, DLF occurred in 1 and 14 patients in the LOW group and the HIGH group (1.6% and 10.7%, log-rank p = .043), respectively. The incidence of any unplanned revascularization was also significantly lower in the LOW group than in the HIGH group (3.3% vs. 14.5%, log-rank p = .032). CONCLUSIONS: The incidence of DLF was significantly lower in the patients with LDL-C < 70 mg/dL than in those with LDL-C ≥ 70 mg/dL at the first follow-up after FFR-based deferral of revascularization.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2019) conducted an observational in stable coronary artery disease (n=192). Intensively lowered LDL-C (<70 mg/dL) vs. LDL-C ≥70 mg/dL was evaluated on Deferred lesion failure (DLF) defined as the composite of deferred lesion revascularization and deferred vessel myocardial infarction (p=.043). Intensively lowered LDL-C was associated with a lower incidence of deferred lesion failure compared to LDL-C ≥/dL.
Synapse has enriched 10 related papers. Consider them for comparative context: